Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Equity Method Investments Narrative (Details)

v3.3.1.900
Acquisitions, Investments, and Licenses - Equity Method Investments Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2015
USD ($)
Schedule of Equity Method Investments [Line Items]  
Total assets of equity method investees $ 383.1
Total liabilities of equity method investees 61.6
Net losses of equity method investees (73.3)
Market value of equity method investees $ 89.6
Pharmsynthez  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 17.00%
NIMS  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 1.00%
Levon Resources Ltd  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 25.00%
InCellDx, Inc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 27.00%
Neovasc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 4.00%
Cocrystal Pharma  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 8.00%
Sevion  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 3.00%